Assessment of oral transmission using cell-free human immunodeficiency virus-1 in mice reconstituted with human peripheral blood leucocyte

Immunology

Volumn 109, Issue 2, 2003, Pages 271-282

  Nakao, Ryoma ^a   Hanada, Nobuhiro ^b   Asano, Toshihiko ^c   Hara, Takashi ^c   Salam, Abdus ^c   Matin, Khairul ^b   Shimazu, Yoshihito ^d   Nakasone, Tadashi ^c   Horibata, Shigeo ^c   Aoba, Takaaki ^d   Honda, Mitsuo ^c   Amagasa, Teruo ^a   Senpuku, Hidenobu ^c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CELL FREE SYSTEM; CELL STIMULATION; CONTROLLED STUDY; GINGIVA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE; MOUSE; MOUSE STRAIN; MOUTH CAVITY; MOUTH INFECTION; MOUTH MUCOSA; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SCID MOUSE; T LYMPHOCYTE; TISSUE INJURY; VIRUS CONCENTRATION; VIRUS TRANSMISSION;

ANIMALS; CELL TRANSPLANTATION; CELL-FREE SYSTEM; DISEASE MODELS, ANIMAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-4; MICE; MICE, INBRED NOD; MICE, SCID; MOUTH MUCOSA; PERIODONTIUM; POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS;

EID: 0038519424     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01644.x     Document Type: Article

References (47)

1. Goedert JJ, Duliege AM, Amos CI, Felton S, Biggar RJ. High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet 1991; 338:1471-5.
2. Nduati R, John G, Mbori-Ngacha D et al. Effect of breastfeeding and formula feeding on transmission of HIV-1. JAMA 2000; 283:1167-74.
3. Rothenberg RB, Scarlett M, del Rio C, Reznik D, O'Daniels C. Oral transmission of HIV. AIDS 1998; 12:2095-105.
4. Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125:257-64.
5. Baba TW, Trichel AM, An L, Liska V, Martin LN, Murphey-Corb M, Ruprecht RM. Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science 1996; 272:1486-9.
6. Hofmann-Lehmann R, Vlasak J, Rasmussen RA et al. Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J Virol 2001; 75:7470-80.
7. Mermin JH, Holodniy M, Katzenstein DA, Merigen TC. Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. J Infect Dis 1991; 164:769-72.
8. Moore JS, Hall SD, Jackson S. Cell-associated HIV-1 infection of salivary gland epithelial cell line. Virology 2002; 297:89-97.
9. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335:256-9.
10. Greiner DL, Shultz LD, Yates J et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol 1995; 146:888-902.
11. Mosier DE, Gulizia RJ, Baird SM, Wilson DB, Spector DH, Spector SA. Human immunodeficiency virus infection of human-PBL-SCID mice. Science 1991; 251:791-4.
12. Hesselton RM, Greiner DL, Mordes JP, Rajan TV, Sullivan JL, Shultz LD. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. J Infect Dis 1995; 172:974-82.
13. Kataoka S, Satoh J, Fujiya H, Toyota T, Suzuki R, Itoh K, Kumagai K. Immunologic aspects of the nonobese diabetic (NOD) mouse: abnormalities of cellular immunity. Diabetes 1983; 32:247-53.
14. Serreze DV, Gaskins HR, Leiter EH. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 1993; 150:2534-43.
15. Baxter AG, Cooke A. Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. Diabetes 1993; 42:1574-8.
16. Serreze DV, Gaedeke JW, Leiter EH. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci U S A 1993; 90:9625-9.
17. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci U S A 1990; 87:968-72.
18. + T cells. Science 1990; 248:1227-30.
19. Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D. MHC class 1 deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991; 253:199-202.
20. + cytolytic T cells. Nature 1990; 344:742-6.
21. + T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol 1997; 158:3578-86.
22. Senpuku H, Asano T, Matin K et al. Effects of human IL-18 and IL-12 treatment on human lymphocyte engraftment in NOD-scid mice. Immnology 2002; 107:232-42.
23. Paul WE. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991; 77:1859-70.
24. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76:241-51.
25. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993; 362:245-8.
26. Liew FY. T (H) 1 and T (H) 2 cells: a historical perspective. Nat Rev Immunol 2002; 2:55-60.
27. Stahl-Hennig C, Steinman RM, Tenner-Racz K et al. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science 1999; 285:1261-5.
28. Robert-Guroff M. IgG surfaces as an important component in mucosal protection. Nat Med 2000; 6:129-30.
29. Zazzi M, Romano L, Brasini A, Valensin PE. Simultaneous amplification of multiple HIV-1 DNA sequences from clinical specimens by using nested-primer polymerase chain reaction. AIDS Res Hum Retroviruses 1993; 9:315-20.
30. Leitner T, Escanilla D, Marquina S, Wahlberg J, Brostrom C, Hansson HB, Uhlen M, Albert J. Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden. Virology 1995; 209:136-46.
31. Kuhn R, Rajewsky K, Muller W. Generation and analysis of interleukin-4 deficient mice. Science 1991; 254:707-10.
32. Bombil F, Latinne D, Kints J-P, Bazin H. Human recombinant interleukin-4 (HurIL-4) improves SCID mouse reconstitution with human peripheral blood lymphocytes. Immunobiology 1996; 196:437-48.
33. Akbar AN, Salmon M. Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol Today 1997; 18:72-6.
34. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996; 272:54-60.
35. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993; 261:1179-81.
36. Moore JS, Hall SD, Jackson S. Cell-associated HIV-1 infection of salivary gland epithelial cell lines. Virology 2002; 297:89-97.
37. Ray PE, Liu XH, Henry D, Dye L 3rd, Xu L, Orenstein JM, Schuztbank TE. Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int 1998; 53:1217-29.
38. + cells. Nat Med 2002; 8:150-6.
39. Prakash K, Hodinka RL, Hullihen DM, Plotkin SA. Isolation and characterization of an infectious molecular clone of the MN strain of HIV-1. Biochem Biophys Res Commun 1991; 179:1377-83.
40. Spear GT, al-Harthi L, Sha B, Saarloos MN et al. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS 1997; 11:1319-26.
41. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 1995; 96:456-64.
42. Shugars DC, Wahl SM. The role of the oral environment in HIV-1 transmission. J Am Dent Assoc 1998; 129:851-8.
43. Crombie R, Silverstein RL, MacLow C, Pearce SF, Nachman RL, Laurence J. Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med 1998; 187:25-35.
44. Baron S, Poast J, Richardson CJ, Nguyen D, Cloyd M. Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: a novel mechanism. J Infect Dis 2000; 181:498-504.
45. Dillon B, Hecht FM, Swanson M et al. Primary HIV infections associated with oral transmission. In: Thompson MA, ed. Proceedings of the 7th Conference on Retroviruses and Opportunistic Infections: Foundation for Retrovirology and Human Health. San Francisco, CA. 2000; Abstract 473.
46. Yeung SC, Kazazi F, Randle CG et al. Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal disease. J Infect Dis 1993; 167:803-9.
47. Serb P, Yeung S. HIV infection and the dentist. 1. The presence of HIV in saliva and its implications to dental practice. Aust Dent J 1994; 39:67-72.